
Manuel Vázquez Carrera
Jefe de Grupo Senior
The researcher Manuel Vázquez Carrera graduated in Pharmacy in 1990 from the University of Barcelona and received his Doctor of Pharmacology degree from the University of Barcelona in 1994.
Between 1996 and 2001 he spent a postdoctoral stay at the Institut de Biologie Animale de la Université de Lausanne where he studied the mechanisms of action of the nuclear receptor PPARα.
In 1997 he got a position of full professor at the University of Barcelona and since 2017 he has been full professor of the same university. However, he is a principal researcher at CIBERDEM.
He is currently leading the research group Pharmacological Targets for Inflammation and Metabolic Diseases, where he studies the mechanisms involved in the relationship between inflammation and the development of insulin resistance and diabetic cardiomyopathy.
Professional network profiles
Last Publications
- Montori M, Aguilar-Recarte D, Zarei M, Pizarro J, Palomer FX and Vazquez M Endoplasmic reticulum stress downregulates PGC-1a in skeletal muscle through ATF4 and an mTOR-mediated reduction of CRTC2. CELL COMMUNICATION AND SIGNALING . 20(1): 53-53.
- Sepúlveda-Fragoso V, Alexandre-Santos B, Salles ACP, Proença AB, de Paula Alves AP, Vazquez M, da Nóbrega ACL, Frantz EDC and Magliano DC Crosstalk between the renin-angiotensin system and the endoplasmic reticulum stress in the cardiovascular system: Lessons learned so far. LIFE SCIENCES . 284: 119919-119919.
- García-Torra V, Cano A, Espina M, Ettcheto M, Camins A, Barroso E, Vazquez M, García ML, Sánchez-López E and Souto EB State of the Art on Toxicological Mechanisms of Metal and Metal Oxide Nanoparticles and Strategies to Reduce Toxicological Risks. Toxics . 9(8): 195.